A chemist's view of melanogenesis

被引:386
|
作者
Ito, S [1 ]
机构
[1] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi 4701192, Japan
来源
PIGMENT CELL RESEARCH | 2003年 / 16卷 / 03期
关键词
cysteinyldopa; 5,6-dihydroxyindole; 5,6-dihydroxyindole-2-carboxylic acid; eumelanin; pheomelanin;
D O I
10.1034/j.1600-0749.2003.00037.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The significance of our understanding of the chemistry of melanin and melanogenesis is reviewed. Melanogenesis begins with the production of dopaquinone, a highly reactive o -quinone. Pulse radiolysis is a powerful tool to study the fates of such highly reactive melanin precursors. Based on pulse radiolysis data reported by Land et al . (J Photochem Photobiol B: Biol 2001;64:123) and our biochemical studies, a pathway for mixed melanogenesis is proposed. Melanogenesis proceeds in three distinctive steps. The initial step is the production of cysteinyldopas by the rapid addition of cysteine to dopaquinone, which continues as long as cysteine is present (1 muM). The second step is the oxidation of cysteinyldopas to give pheomelanin, which continues as long as cysteinyldopas are present (10 muM). The last step is the production of eumelanin, which begins only after most cysteinyldopas are depleted. It thus appears that eumelanin is deposited on the preformed pheomelanin and that the ratio of eu- to pheomelanin is determined by the tyrosinase activity and cysteine concentration. In eumelanogenesis, dopachrome is a rather stable molecule and spontaneously decomposes to give mostly 5,6-dihydroxyindole. Dopachrome tautomerase (Dct) catalyses the tautomerization of dopachrome to give mostly 5,6-dihydroxyindole-2-carboxylic acid (DHICA). Our study confirmed that the role of Dct is to increase the ratio of DHICA in eumelanin and to increase the production of eumelanin. In addition, the cytotoxicity of o -quinone melanin precursors was found to correlate with binding to proteins through the cysteine residues. Finally, it is still unknown how the availability of cysteine is controlled within the melanosome.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [41] Some contributions of chemical synthesis to glycobiology: An organic chemist's point of view
    Garegg, PJ
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (04) : 345 - 364
  • [42] A brief history of Pfizer Central Research - A medicinal chemist's view.
    Lombardino, JG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U898 - U898
  • [43] Drugging the undruggable: a computational chemist's view of KRASG12C
    Bodnarchuk, Michael S.
    Cassar, Doyle J.
    Kettle, Jason G.
    Robb, Graeme
    Ward, Richard A.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (04): : 609 - 614
  • [44] Analytical chemist's view of over 10 years of improving the IBM thinkpad.
    Chao, JL
    Sloop, CC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U82 - U82
  • [45] A theoretical chemist in industry: A personal view.
    DeBolt, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U560 - U560
  • [46] The quest for the ideal biocide: Nature versus synthetic molecules? The chemist's point of view
    Gimenez-Arnau, E.
    REVUE FRANCAISE D ALLERGOLOGIE, 2015, 55 (03): : 210 - 211
  • [47] What can a chemist learn from nature’s macrocycles? – A brief, conceptual view
    Ludger A. Wessjohann
    Eelco Ruijter
    Daniel Garcia-Rivera
    Wolfganf Brandt
    Molecular Diversity, 2005, 9 : 171 - 186
  • [48] A Chemist's View on Electronic and Steric Effects of Surface Ligands on Plasmonic Metal Nanostructures
    Kim, Yoonhee
    Ji, Soohyun
    Nam, Jwa-Min
    ACCOUNTS OF CHEMICAL RESEARCH, 2023, 56 (16) : 2139 - 2150
  • [49] From monolayers to nanostructured materials: An organic chemist's view of self-assembly
    Bethell, D
    Brust, M
    Schiffrin, DJ
    Kiely, C
    JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 1996, 409 (1-2): : 137 - 143
  • [50] Laser crystals: a materials chemist point of view
    Vivien, D
    ROMOPTO 2003: SEVENTH CONFERENCE ON OPTICS, 2004, 5581 : 56 - 64